Oculis Holding AG (OCS) Income towards Parent Company (2022 - 2026)

Oculis Holding AG (OCS) recorded quarterly Income towards Parent Company of -$37.1 million in Q1 2026, down 151.01% quarter-over-quarter from $72.7 million in Q4 2025, and little changed on a YoY basis from -$37.3 million in Q1 2025.

Oculis Holding AG (OCS) Income towards Parent Company (2022 - 2026) Analysis & Trends

Oculis Holding AG's Income towards Parent Company history runs 5 years deep, the most recent figure standing at -$37.1 million for Q1 2026.

  • In Q1 2026, Income towards Parent Company changed 0.46% year-over-year to -$37.1 million; the TTM figure through Mar 2026 stood at -$21.0 billion (up 9.94% YoY), while the FY2025 annual figure was -$124.3 million, down 26.45% from the prior year.
  • Income towards Parent Company was -$37.1 million for Q1 2026 at Oculis Holding AG, down from $72.7 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $72.7 million in Q4 2025 to a low of -$23.3 billion in Q3 2024.
  • Historically, Income towards Parent Company has averaged -$2.8 billion across 5 years, with a median of -$21.5 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Income towards Parent Company slumped 116344.35% in 2024, then surged 318.67% in 2025.
  • A 5-year view of Income towards Parent Company shows it stood at -$9.6 million in 2022, then plunged by 47.68% to -$14.1 million in 2023, then sank by 135.51% to -$33.3 million in 2024, then soared by 318.67% to $72.7 million in 2025, then plunged by 151.01% to -$37.1 million in 2026.
  • The last three Income towards Parent Company figures came in at -$37.1 million (Q1 2026), $72.7 million (Q4 2025), and -$21.0 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn -
7 Psyence Biomedical 229.39 Bn 229.38 Bn -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn
9 Abivax 90.15 Bn 90.15 Bn -
10 Oculis Holding AG 8.23 Bn 7.92 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -37.09 Mn
Dec 31, 2025 72.72 Mn
Sep 30, 2025 -21.04 Bn
Jun 30, 2025 -30.71 Mn
Mar 31, 2025 -36.93 Mn
Dec 31, 2024 -33.25 Mn
Sep 30, 2024 -23.26 Bn
Jun 30, 2024 -22.98 Mn
Mar 31, 2024 -18.37 Mn
Dec 31, 2023 -14.12 Mn
Sep 30, 2023 -19.98 Mn
Jun 30, 2023 -14.07 Mn
Mar 31, 2023 -49.48 Mn
Dec 31, 2022 -9.56 Mn
Sep 30, 2022 -10.29 Mn
Jun 30, 2022 -12.73 Mn